10-K
Annual Report
SONOMA PHARMACEUTICALS, INC.
SNOA
NASDAQ
CIK: 1367083
File #: 001-33216
Balance Sheet
38 line items · 2 periods
XBRL
| Item | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 3,128,000 | 3,820,000 |
Accounts Receivable | 2,898,000 | 2,572,000 |
Inventory | 2,719,000 | 2,858,000 |
Other Non-Operating Current Assets | 3,541,000 | 4,308,000 |
Current portion of deferred consideration, net of discount | 262,000 | 240,000 |
Total current assets | 12,548,000 | 13,798,000 |
Property, Plant and Equipment | 365,000 | 488,000 |
Operating Lease Right-of-Use Asset | 286,000 | 418,000 |
Deferred Tax Assets, Non-Current | 1,145,000 | 949,000 |
Deferred consideration, net of discount, less current portion | 330,000 | 505,000 |
Other Non-Operating Non-Current Assets | 66,000 | 73,000 |
Total assets | 14,740,000 | 16,231,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 607,000 | 841,000 |
Accounts Payable | 2,113,000 | 2,029,000 |
Other Current Liabilities | 478,000 | 160,000 |
Short-Term Debt | 323,000 | 431,000 |
Operating Lease Liability, Current | 198,000 | 256,000 |
Total current liabilities | 3,719,000 | 3,717,000 |
Warranty and Other Provisions | 87,000 | 140,000 |
Withholding tax payable | 4,710,000 | 4,235,000 |
Operating Lease Liability, Non-Current | 87,000 | 162,000 |
Total liabilities | 8,603,000 | 8,254,000 |
Stockholders’ Equity: | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 2,000 | 5,000 |
Total Stockholders' Equity | 203,207,000 | 200,904,000 |
Total Stockholders' Equity | (194,349,000) | (189,514,000) |
Total Stockholders' Equity | (2,723,000) | (3,418,000) |
Total stockholders’ equity | 6,137,000 | 7,977,000 |
Common Stock | 2,000 | 5,000 |
Additional Paid-in Capital | 203,207,000 | 200,904,000 |
Retained Earnings | (194,349,000) | (189,514,000) |
AOCI Attributable to Parent | (2,723,000) | (3,418,000) |
Total liabilities and stockholders’ equity | 14,740,000 | 16,231,000 |